Clicky

Farmsintez OAO(LIFE)

Description: Public Joint-Stock Company "Pharmsynthez', a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company "Pharmsynthez' has partnership with HiFiBiO Therapeutics Inks for the clinical development and commercialization of its SARS-CoV-2 neutralizing antibody in Russia. Public Joint-Stock Company "Pharmsynthez' was founded in 1996 and is based in St. Petersburg, Russia.


Keywords: Pharmaceutical Herbalism Tuberculosis Severe Acute Respiratory Syndrome Related Coronavirus Pharmacopoeias Sars Co V 2

Home Page: www.pharmsynthez.com

25 Krasnovo Kursanta Str
Saint Petersburg, 197110
Russia
Phone: 7 812 329 8080


Officers

Name Title
Mr. Petr Vladimirovich Kurglyakov Director Gen.
Barkanova Anna Borisovna Chief Accountant
Mr. Yury Iosifovich Maylis Chief Power Engineer
Surkov Kirill Gennadievich Head of Research & Department and Member of Audit Commission

Exchange: MCX

Country: RU

Currency: Russian Rouble (₽)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.4043
Price-to-Sales TTM: 3.0047
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks